These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15598430)

  • 21. Chemotactic tripeptides incorporating at position 2 alpha-aminoacid residues with unsaturated side chains.
    Lucente G; Paradisi MP; Giordano C; Sansone A; Torino D; Spisani S
    Amino Acids; 2008 Aug; 35(2):329-38. PubMed ID: 18163179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotactic peptides: fMLF-OMe analogues incorporating proline-methionine chimeras as N-terminal residue.
    Mollica A; Paradisi MP; Varani K; Spisani S; Lucente G
    Bioorg Med Chem; 2006 Apr; 14(7):2253-65. PubMed ID: 16303307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils.
    Cavicchioni G; Fraulini A; Turchetti M; Varani K; Falzarano S; Pavan B; Spisani S
    Eur J Pharmacol; 2005 Apr; 512(1):1-8. PubMed ID: 15814083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-activity relationship of for-L-Met L-Leu-L-Phe-OMe analogues in human neutrophils.
    Cavicchioni G; Fraulini A; Falzarano S; Spisani S
    Bioorg Chem; 2006 Oct; 34(5):298-318. PubMed ID: 16919307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New fMLF-OMe analogues containing constrained mimics of phenylalanine residue.
    Torrini I; Mastropietro G; Pagani Zecchini G; Paglialunga Paradisi M; Lucente G; Spisani S
    Arch Pharm (Weinheim); 1998 May; 331(5):170-6. PubMed ID: 9691248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotactic peptide analogues. Centrally constrained chemotactic N-formyltripeptides: synthesis, conformation, and activity of two new analogues.
    Pagani Zecchini G; Paglialunga Paradisi M; Torrini I; Lucente G; Mastropietro G; Paci M; Spisani S
    Arch Pharm (Weinheim); 1996 Dec; 329(12):517-23. PubMed ID: 9038418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological activity in human neutrophils of di-tripeptides, analogues of the chemotactic fMLP.
    Cavicchioni G; Turchetti M; Spisani S
    Bioorg Med Chem Lett; 2001 Dec; 11(24):3157-9. PubMed ID: 11720864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biscarbamate analogues of the chemotactic tripeptide fMLF-OMe.
    Zecchini GP; Paradisi MP; Torrini I; Nalli M; Lucente G; Spisani S
    Farmaco; 2000 Apr; 55(4):308-13. PubMed ID: 10966163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudopeptides containing the 2-hydrazonoacyl fragment: analogs of the chemotactic agent HCO-Met-Leu-Phe-OMe.
    Torrini I; Nalli M; Paglialunga Paradisi M; Pagani Zecchini G; Lucente G; Spisani S
    J Pept Res; 2001 Jul; 58(1):56-66. PubMed ID: 11454170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH.
    Selvatici R; Falzarano S; Franceschetti L; Mollica A; Guerrini R; Siniscalchi A; Spisani S
    FEBS J; 2008 Feb; 275(3):449-57. PubMed ID: 18167144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and activity on human neutrophil functions of fMLF-OMe analogs containing alkyl spacers at the central position.
    Pagani Zecchini G; Morera E; Nalli M; Paglialunga Paradisi M; Lucente G; Spisani S
    Farmaco; 2001 Nov; 56(11):851-8. PubMed ID: 11765037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modified chemotactic peptides: synthesis, conformation, and biological activity of For-Thp-Leu-delta ZPhe-OMe.
    Torrini I; Zecchini GP; Paglialunga Paradisi M; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S; Cerichelli G
    Biopolymers; 1994 Oct; 34(10):1291-302. PubMed ID: 7948717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modified chemotactic peptides: synthesis, conformation, and activity of HCO-Thp-Ac6c-Phe-OMe.
    Torrini I; Pagani Zecchini G; Paglialunga Paradisi M; Lucente G; Mastropietro G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S
    Biopolymers; 1996 Sep; 39(3):327-37. PubMed ID: 8756513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A hydrophilic residue at position 2 can improve specific biological responses in fMLP-OMe analogs.
    Cavicchioni G; Spisani S
    J Pept Res; 2001 Sep; 58(3):257-62. PubMed ID: 11576332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide.
    Cavicchioni G; Turchetti M; Varani K; Falzarano S; Spisani S
    Bioorg Chem; 2003 Aug; 31(4):322-30. PubMed ID: 12877881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modified chemotactic peptides: synthesis, crystal conformation, and activity of For-Hse(Me)-Leu-Phe-OMe.
    Torrini I; Pagani Zecchini G; Paglialunga Paradisi M; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S
    Biopolymers; 1994 Jan; 34(1):1-9. PubMed ID: 8110962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformational investigations on analogs of inflammation response inducing chemotactic tripeptide fMLP.
    Rathore RS
    Biopolymers; 2005; 80(5):651-64. PubMed ID: 15648091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acylated tripeptides as chemotaxin antagonists (author's transl)].
    Opitz W; Fruchtmann R
    Hoppe Seylers Z Physiol Chem; 1981 Aug; 362(8):1037-41. PubMed ID: 7346374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological variation responses in fMLP-OMe analogs, introducing bulky protecting groups on the side-chain of hydrophilic residues at position 2.
    Cavicchioni G; Turchetti M; Spisani S
    J Pept Res; 2002 Oct; 60(4):223-31. PubMed ID: 12366529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probing structural requirements of fMLP receptor: on the size of the hydrophobic pocket corresponding to residue 2 of the tripeptide.
    Spisani S; Traniello S; Cavicchioni G; Formaggio F; Crisma M; Toniolo C
    J Pept Sci; 2002 Feb; 8(2):56-65. PubMed ID: 11860029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.